A detailed history of Cable Hill Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cable Hill Partners, LLC holds 5,715 shares of BMY stock, worth $330,784. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,715
Holding current value
$330,784
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$39.66 - $51.75 $226,656 - $295,751
5,715 New
5,715 $295,000
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $17,610 - $19,974
268 Added 9.21%
3,178 $220,000
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $2,944 - $3,486
-43 Reduced 1.46%
2,910 $209,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $383 - $226,908
2,953 New
2,953 $210,000
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $63,806 - $70,556
-1,430 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $135 - $161
3 Added 0.21%
1,430 $68,000
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $195 - $252
4 Added 0.28%
1,427 $74,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $165 - $186
3 Added 0.21%
1,423 $89,000
Q2 2018

Aug 03, 2018

BUY
$50.53 - $62.98 $151 - $188
3 Added 0.21%
1,420 $79,000
Q1 2018

Apr 20, 2018

SELL
$59.92 - $68.98 $1,438 - $1,655
-24 Reduced 1.67%
1,417 $86,000
Q4 2017

Feb 22, 2018

SELL
$59.94 - $65.35 $5,574 - $6,077
-93 Reduced 6.06%
1,441 $89,000
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $6,903 - $7,967
125 Added 8.87%
1,534 $98,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,409
1,409 $79,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.